Study of TS-1 as 2nd Line Treatment in Patients With Advanced Metastatic Breast Cancer
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01492543 |
|
Recruitment Status
: Unknown
Verified March 2013 by Binghe Xu, Chinese Academy of Medical Sciences.
Recruitment status was: Recruiting
First Posted
: December 15, 2011
Last Update Posted
: March 15, 2013
|
Sponsor:
Chinese Academy of Medical Sciences
Collaborators:
Beijing Cancer Hospital
Beijing Chao Yang Hospital
Chinese PLA General Hospital
China-Japan Friendship Hospital
Tianjin Medical University Cancer Institute and Hospital
Hebei Tumor Hospital
Information provided by (Responsible Party):
Binghe Xu, Chinese Academy of Medical Sciences
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Unknown |
|---|---|
| Estimated Primary Completion Date : | April 2014 |
| Estimated Study Completion Date : | October 2014 |